Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Rilpl2 ELISA Kit (AC3649)
Cat.#: ASET-2238
Specifications
Description Mouse Rilpl2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Rilpl2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.15 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2015 Human Visfatin ELISA Kit (AC3426) Quantitative inquiry ASET-1450 Human KCC2 ELISA Kit (AC2861) Quantitative inquiry ASET-1877 Mouse CacyBP ELISA Kit (AC3288) Quantitative inquiry ASET-1843 Human CRCP ELISA Kit (AC3254) Quantitative inquiry ASET-1042 Human Pannexin 1 ELISA Kit (AC2453) Quantitative inquiry ASET-2406 Hamster IL-6 ELISA Kit (AC3817) Quantitative inquiry ASET-1127 Rat TRPV1 ELISA Kit (AC2538) Quantitative inquiry ASET-2320 Mouse Semaphorin 3A ELISA Kit (AC3731) Quantitative inquiry ASET-2480 Human WFS1 ELISA Kit (AC3891) Quantitative inquiry ASET-1390 Mouse Clathrin Light Chain ELISA Kit (AC2801) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket